Mativ(US:MATV)2026-02-18 21:07Financial Performance - Q4 2025 sales reached $463.1 million, a 1.0% increase year-over-year, with adjusted EBITDA of $53.5 million, up 19% from the previous year[7] - Full-year 2025 sales totaled $1,987.0 million, a 0.3% increase year-over-year, with record free cash flow of $93.8 million, up 139% compared to the prior year[7] - Adjusted EBITDA margin for Q4 2025 was 11.6%, an increase of 180 basis points year-over-year, while full-year adjusted EBITDA margin was 11.3%, up 30 basis points[7] - The company reported a net income of $100.8 million in Q4 2025, a significant increase from $1.5 million in Q4 2024[31] - The net income for the year ended December 31, 2025, was $100.8 million, a significant improvement from a net loss of $337.4 million in 2024[42] - Adjusted EBITDA for the year ended December 31, 2025, reached $224.7 million, up from $218.0 million in 2024, indicating a 3% growth[42] - The diluted earnings per share for the three months ended December 31, 2025, was $1.80, a significant increase from $0.03 in the same period of 2024[41] - Adjusted income for the year ended December 31, 2025, was $42.6 million, compared to $34.1 million in 2024, reflecting a 25% increase[41] Segment Performance - The Filtration & Advanced Materials segment reported Q4 2025 sales of $177.2 million, a 5.6% increase from Q4 2024, driven by higher volume and favorable currency translation[8] - The Sustainable & Adhesive Solutions segment had Q4 2025 sales of $285.9 million, down 1.7% year-over-year, primarily due to lower volume/mix despite favorable currency translation[10] - The FAM segment reported net sales of $177.2 million, a 5.6% increase from $167.8 million in the same period last year[34] - The SAS segment experienced a slight decline in net sales, down 1.7% to $285.9 million from $290.8 million[34] - Adjusted operating profit for the FAM segment increased by 14.8% to $26.3 million, with a return on net sales of 14.8%[37] - The SAS segment's adjusted operating profit rose by 9.3% to $26.7 million, achieving a return on net sales of 9.3%[37] Cash Flow and Debt - Cash from operating activities for the full year 2025 was $133.8 million, a 41% increase compared to the previous year[7] - Total debt as of December 31, 2025, was $1,018.2 million, with net debt of $934.0 million after accounting for cash and cash equivalents of $84.2 million[16] - Cash and cash equivalents at the end of 2025 were $89.8 million, down from $94.3 million at the end of 2024[33] - Total debt as of December 31, 2025, was $1,018.2 million, down from $1,089.3 million in 2024[42] - Net debt decreased to $934.0 million as of December 31, 2025, compared to $995.0 million in 2024, showing a reduction of 6%[42] - Free cash flow for the year ended December 31, 2025, was $93.8 million, compared to $39.2 million in 2024, representing an increase of 139%[42] Operational Highlights - Management highlighted a focus on disciplined operational execution and prudent inventory management as key drivers of performance in 2025[5] - The company anticipates continued growth and value creation in 2026, despite navigating an environment of anemic market demand[6] - Organic growth for the consolidated Mativ was 1.9% for the three months ended December 31, 2025[40] Impairments and Expenses - The company experienced a goodwill impairment expense of $411.9 million in 2025, compared to none in 2024[33] - The company reported a significant increase in restructuring and impairment expenses, totaling $431.8 million for the year ended December 31, 2025, compared to $38.1 million in 2024[36] Assets and Liabilities - Total assets decreased to $2,051.6 million in 2025 from $2,447.9 million in 2024[32] - Long-term debt decreased to $1,015.3 million in 2025 from $1,086.7 million in 2024[32] - The company’s total liabilities decreased slightly to $1,552.9 million in 2025 from $1,589.4 million in 2024[32]